Volume | 119,800 |
|
|||||
News | - | ||||||
Day High | 2.8999 | Low High |
|||||
Day Low | 2.01 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
GlucoTrack Inc | GCTK | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
2.01 | 2.01 | 2.8999 | 2.32 | 2.0687 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
824 | 119,800 | US$ 2.42 | US$ 289,485 | - | 0.664 - 4.95 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:02:19 | 4 | US$ 2.19 | USD |
GlucoTrack Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
48.47M | 20.89M | - | 0 | -7.1M | -0.34 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
GlucoTrack News
Date | Time | Source | News Article |
---|---|---|---|
5/24/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
5/20/2024 | 07:45 | Edgar (US Regulatory) | Form 8-K - Current report |
5/16/2024 | 07:42 | Edgar (US Regulatory) | Form 8-K - Current report |
5/16/2024 | 07:30 | GlobeNewswire Inc. | GLUCOTRACK’S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES.. |
5/15/2024 | 16:17 | Edgar (US Regulatory) | Form 8-K - Current report |
5/15/2024 | 16:12 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
5/15/2024 | 15:15 | GlobeNewswire Inc. | GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT |
5/08/2024 | 15:38 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
5/02/2024 | 08:00 | GlobeNewswire Inc. | GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER.. |
4/22/2024 | 13:10 | GlobeNewswire Inc. | GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT |
4/17/2024 | 07:00 | InvestorsHub NewsWire | Glucotrack Announces Expansion of Its Continuous Glucose.. |
4/16/2024 | 07:30 | GlobeNewswire Inc. | GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GCTK Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.12 | 2.8999 | 2.00 | 2.07 | 14,386 | 0.20 | 9.43% |
1 Month | 2.65 | 3.95 | 1.9701 | 3.05 | 108,569 | -0.33 | -12.45% |
3 Months | 1.555 | 4.95 | 1.3195 | 2.63 | 192,575 | 0.765 | 49.20% |
6 Months | 1.049 | 4.95 | 0.90 | 2.00 | 172,132 | 1.27 | 121.16% |
1 Year | 2.10 | 4.95 | 0.664 | 1.57 | 188,414 | 0.22 | 10.48% |
3 Years | 15.80 | 21.20 | 0.664 | 8.99 | 411,841 | -13.48 | -85.32% |
5 Years | 15.80 | 21.20 | 0.664 | 8.99 | 411,841 | -13.48 | -85.32% |
GlucoTrack Description
GlucoTrack Inc, former Integrity Applications, Inc. is a medical device company. The Company is focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by persons suffering from diabetes. It has developed a non-invasive blood glucose monitor, the GlucoTrack Model DF-F glucose monitoring device, which is designed to help people with diabetes obtain blood glucose level readings without the pain, inconvenience, cost and difficulty of conventional (invasive) spot finger stick devices. The Company operates in Europe, and Asia and Pacific. The GlucoTrack model DF-F utilizes a combination of ultrasound, electromagnetic and thermal technologies to obtain blood glucose measurements in less than one minute through a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood. |